
Organization · Accelerator
HiveBio.io
HiveBio is a virtual accelerator program dedicated to supporting life science startups, particularly those founded by individuals from underserved communities. It aims to reshape the landscape of life science entrepreneurship globally.
Overview
What HiveBio.io does
What HiveBio.io is
HiveBio is a virtual accelerator program dedicated to supporting life science startups, particularly those founded by individuals from underserved communities. It aims to reshape the landscape of life science entrepreneurship globally.
How it participates in the startup ecosystem
The current public profile supports funder and program host and event host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Founded
- Founded in 2023
- Approximate age
- About 3 years
- Structured capabilities
- Funder · Program host · Event host
- Last reviewed
- March 16, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find HiveBio.io elsewhere
Open the official website or a supported primary organization account.
Capability profile
HiveBio.io as a funder
Investment thesis
HiveBio is dedicated to supporting life science startups, particularly those founded by individuals from underserved communities, aiming to reshape the landscape of life science entrepreneurship globally.
Focus narrative
HiveBio invests in early-stage biotech entrepreneurs, specifically targeting sectors such as biopharma, medical devices, digital health, and healthcare data. The organization supports companies involved in drug development, regenerative medicine, AI diagnostics, and medical prosthetics. The program is designed to empower founders from diverse backgrounds, including first-generation founders, females, nonbinary individuals, LGBTQ+ community members, BIPOC, and immigrant entrepreneurs.
Value beyond capital
HiveBio provides mentorship and resources to help startups grow and scale, supporting early-stage biotech entrepreneurs at no cost to participants.
Focus and fit
- Stages
- Accelerator · Pre-seed · Seed
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 9
Portfolio context
HiveBio's inaugural cohort includes notable companies such as Ajaya Bio, developing BOLT-360™, a bispecific platform for autoimmune diseases and oncology; BioLattice Ophthalmics, innovating biomimetic scaffolds for ophthalmic tissue replacement; and Bound Therapeutics, creating novel cancer therapies for triple-negative breast cancer. Other companies include Cerespectus, DRS.LINQ, Higher Medicine, QuneUp, Trevarx Biomedical, Valfard Therapeutics, and Vasowatch.
Capability profile
HiveBio.io as a program host
Program thesis
HiveBio is a virtual accelerator program focused on supporting life science startups, particularly those founded by individuals from underserved communities.
Focus narrative
HiveBio invests in early-stage biotech entrepreneurs, specifically targeting sectors such as biopharma, medical devices, digital health, and healthcare data. The program is designed to empower founders from diverse backgrounds, including first-generation founders, females, nonbinary individuals, LGBTQ+ community members, BIPOC, and immigrant entrepreneurs.
Value and support
HiveBio offers mentorship and resources to help startups grow and scale, all at no cost to participants, thanks to funding from the John S. and James L. Knight Foundation.
Format and cadence
- Format
- Remote
Availability
- Application state
- Accepting
- Next deadline
- February 21, 2023
Focus and fit
- Stages
- Accelerator · Pre-seed · Seed
- Regions
- Global
Alumni and track record
- Last recorded cohort
- April 1, 2025
Alumni context
Notable companies from HiveBio's inaugural cohort include Ajaya Bio, developing BOLT-360™ for autoimmune diseases; BioLattice Ophthalmics, innovating biomimetic scaffolds for ophthalmic tissue replacement; and Bound Therapeutics, creating novel cancer therapies for triple-negative breast cancer.
Capability profile
HiveBio.io as an event host
Event focus
HiveBio is a virtual accelerator program dedicated to empowering early-stage biotech entrepreneurs, particularly those from underserved communities. The organization focuses on enhancing access to funding and entrepreneurial opportunities for minority-owned startups in the life sciences sector, including biopharma, medical devices, digital health, and healthcare data.
Format narrative
HiveBio's inaugural accelerator program, Cohort 1, provides mentorship and resources to early-stage biotech entrepreneurs at no cost, supported by the John S. and James L. Knight Foundation. The program includes virtual and in-person meetings to facilitate growth and scaling of startups.
Participant value
HiveBio aims to reshape the landscape of life science entrepreneurship by providing essential resources and support to diverse founders, thereby fostering innovation and inclusivity in the biotech sector.
Format and cadence
- Event types
- demo-day and conference
- Modality
- online
- Startups can present
- Yes
Availability
- Registration state
- Accepting
Audience and fit
- Selection criteria
- open
- Stages
- Pre-seed · Seed
- Audience
- Founders · Investors
- Regions
- Global
Speakers and past editions
Past editions
HiveBio's inaugural cohort includes notable companies such as Ajaya Bio, BioLattice Ophthalmics, Bound Therapeutics, and more, each working on innovative solutions in the biotech field.
Connected ecosystem
Continue from HiveBio.io
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Common questions
What to know about HiveBio.io
Upseed classifies HiveBio.io under the Accelerator organization type. Its current public profile includes funder, program host, and event host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 16, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.